title: Successful treatment with rituximab and donor lymphocyte infusions for fulminant EBV-associated lymphoproliferative disorder that developed 14 years after unrelated BMT.
authors.forename: T
authors.initials: T
authors.lastname: Kawaguchi
authors.forename: S
authors.initials: S
authors.lastname: Tsukamoto
authors.forename: C
authors.initials: C
authors.lastname: Ohwada
authors.forename: M
authors.initials: M
authors.lastname: Takeuchi
authors.forename: T
authors.initials: T
authors.lastname: Muto
authors.forename: S
authors.initials: S
authors.lastname: Tanaka
authors.forename: S
authors.initials: S
authors.lastname: Sakai
authors.forename: Y
authors.initials: Y
authors.lastname: Takeda
authors.forename: D
authors.initials: D
authors.lastname: Abe
authors.forename: E
authors.initials: E
authors.lastname: Sakaida
authors.forename: N
authors.initials: N
authors.lastname: Shimizu
authors.forename: K
authors.initials: K
authors.lastname: Yokote
authors.forename: T
authors.initials: T
authors.lastname: Iseki
authors.forename: K-I
authors.initials: KI
authors.lastname: Imadome
authors.forename: C
authors.initials: C
authors.lastname: Nakaseko
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001782:Blood Donors; D016026:Bone Marrow Transplantation; D020031:Epstein-Barr Virus Infections / Q000628:therapy*; D004854:Herpesvirus 4, Human; D006801:Humans; D017710:Lymphocyte Transfusion; D008232:Lymphoproliferative Disorders / Q000628:therapy* / Q000821:virology; D008297:Male; D008875:Middle Aged; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000628:therapy; D000069283:Rituximab; D013997:Time Factors; D014184:Transplantation, Homologous
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab